Login / Signup

Drugs for COVID-19: An Update.

Jessica CeramellaDomenico IacopettaMaria Stefania SinicropiInmaculada AndreuAnnaluisa MaricondaCarmela SaturninoFederica GiuzioPasquale LongoStefano AquaroAlessia Catalano
Published in: Molecules (Basel, Switzerland) (2022)
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the seventh known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It caused the highly contagious disease called coronavirus disease 2019 (COVID-19), declared a global pandemic by the World Health Organization (WHO) on 11 March 2020. A great number of studies in the search of new therapies and vaccines have been carried out in these three long years, producing a series of successes; however, the need for more effective vaccines, therapies and other solutions is still being pursued. This review represents a tracking shot of the current pharmacological therapies used for the treatment of COVID-19.
Keyphrases
  • coronavirus disease
  • respiratory syndrome coronavirus
  • sars cov
  • endothelial cells
  • south africa
  • induced pluripotent stem cells
  • drug induced